Gonzalez-Cao, M., Mayo de las Casas, C., Jordana Ariza, N., Manzano, J. L., Molina-Vila, M. Á., Soriano, V., Puertolas, T., Balada, A., Soria, A., Majem, M., Montagut, C., Muñoz, E., Rodriguez-Abreu, D., Perez, E., Garcia, A., Cortes, J., Drozdowskyj, A., Karachaliou, N., & Rosell, R. (2018). early evolution of BRAFV600 status in the blood of melanoma patients correlates with clinical outcome and identifies patients refractory to therapy. Melanoma research, 28(3), . http://access.bl.uk/ark:/81055/vdc_100084037012.0x00001c